Bernard Zinman

4 ta ish

University of Toronto

1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

   Bernard Zinman, Christoph Wanner, John M. Lachin +9

   Maqola20156 iqtibos

   ABIABI:AkademIndex/2026.other.282498

2. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

   Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen +12

   MaqolaOAOchiq kirish20164 iqtibos

   ABIABI:AkademIndex/2026.other.057706

3. Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association

   Sarah D. de Ferranti, Ian H. de Boer, Vivian Fonseca +9

   Sharh maqola20142 iqtibos

   ABIABI:AkademIndex/2026.other.676413

4. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

   Vlado Perkovic, Meg Jardine, Bruce Neal +21

   Maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.720708